Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David K Chang

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Journal of Gastroenterology and Hepatology|January 26, 2011
Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreasNam Q Nguyen, Amber L Johns, Anthony J Gill, et al.
Pathology|March 26, 2009
Synoptic reporting improves histopathological assessment of pancreatic resection specimensAnthony J Gill, Amber L Johns, Robert Eckstein, et al.
World Journal of Gastroenterology|July 1, 2014
Personalising pancreas cancer treatment: When tissue is the issueKatrin M Sjoquist, Venessa T Chin, Lorraine A Chantrill, et al.
Plos One|October 25, 2011
Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interactionChristopher J Scarlett, Emily K Colvin, Mark Pinese, et al.
BMC Cancer|September 11, 2012
RON is not a prognostic marker for resectable pancreatic cancerCarole M Tactacan, David K Chang, Mark J Cowley, et al.
International Journal of Oncology|February 20, 2015
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivoJohana M Susanto, Emily K Colvin, Mark Pinese, et al.
Scientific Reports|April 18, 2024
Disruption of the pro-oncogenic c-RAF-PDE8A complex represents a differentiated approach to treating KRAS-c-RAF dependent PDACSean F Cooke, Thomas A Wright, Yuan Yan Sin, et al.
British Journal of Cancer|February 17, 2022
Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancerMeera Patel, Kathryn A F Pennel, Jean A Quinn, et al.
Scientific Reports|October 21, 2016
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinomaPeter Bailey, David K Chang, Marie-Andrée Forget, et al.
Molecular & Cellular Proteomics : MCP|June 5, 2016
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine ProfilingEmily S Humphrey, Shih-Ping Su, Adnan M Nagrial, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Journal of Gastroenterology and Hepatology|January 26, 2011
Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreasNam Q Nguyen, Amber L Johns, Anthony J Gill, et al.
Pathology|March 26, 2009
Synoptic reporting improves histopathological assessment of pancreatic resection specimensAnthony J Gill, Amber L Johns, Robert Eckstein, et al.
World Journal of Gastroenterology|July 1, 2014
Personalising pancreas cancer treatment: When tissue is the issueKatrin M Sjoquist, Venessa T Chin, Lorraine A Chantrill, et al.
Plos One|October 25, 2011
Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interactionChristopher J Scarlett, Emily K Colvin, Mark Pinese, et al.
BMC Cancer|September 11, 2012
RON is not a prognostic marker for resectable pancreatic cancerCarole M Tactacan, David K Chang, Mark J Cowley, et al.
International Journal of Oncology|February 20, 2015
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivoJohana M Susanto, Emily K Colvin, Mark Pinese, et al.
Scientific Reports|April 18, 2024
Disruption of the pro-oncogenic c-RAF-PDE8A complex represents a differentiated approach to treating KRAS-c-RAF dependent PDACSean F Cooke, Thomas A Wright, Yuan Yan Sin, et al.
British Journal of Cancer|February 17, 2022
Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancerMeera Patel, Kathryn A F Pennel, Jean A Quinn, et al.
Scientific Reports|October 21, 2016
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinomaPeter Bailey, David K Chang, Marie-Andrée Forget, et al.
Molecular & Cellular Proteomics : MCP|June 5, 2016
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine ProfilingEmily S Humphrey, Shih-Ping Su, Adnan M Nagrial, et al.
Pageof 9